Bayer, Zydus extend pharma JV by 3 years
German chemical and pharma major Bayer and Ahmedabad-based Cadila Healthcare on Monday extended their pharmaceuticals joint venture by three years from June 2021. The companies...
Continue ReadingGerman chemical and pharma major Bayer and Ahmedabad-based Cadila Healthcare on Monday extended their pharmaceuticals joint venture by three years from June 2021. The companies...
Continue ReadingPharmaceutical drug molecules are becoming increasingly complex, posing challenges in formulation development and manufacturing. This is particularly true of small molecule drug APIs and peptides,...
Continue ReadingThe only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of Covid-19 has been given permission...
Continue ReadingWhile patients jostle to find the drug, Liposomal Amphotericin B, which treats black fungus, workers at Lifecare Innovations, a Gurugram-based pharmaceutical firm, have been working...
Continue ReadingBiological E’s Corbevax, which is undergoing Phase 3 trials, could well be the most affordable vaccine in India priced at below Rs 500 for two...
Continue ReadingPharmEasy has acquired Medlife for an undisclosed amount, the e-pharmacy unicorn said on Tuesday. The deal will make PharmEasy the largest player in the domestic...
Continue ReadingU.S. drugmaker Eli Lilly and Co today said its antibody drug combination has received an emergency use approval in India for the treatment of mild...
Continue ReadingGlenmark Pharma announced the launch of anti-epileptic drug Rufinamide tablets in the US market. Glenmark Pharmaceuticals Ltd has launched Rufinamide tablets USP in the strengths...
Continue ReadingAs the vaccination drive across the country continues, Bharat Biotech’s Covaxin has reached 30 cities, the Indian pharma giant announced. Bharat Biotech Co-founder and Joint...
Continue Reading